Goodrx Holdings Inc
NASDAQ:GDRX
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Goodrx Holdings Inc
Accounts Receivables
Goodrx Holdings Inc
Accounts Receivables Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Accounts Receivables | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
Goodrx Holdings Inc
NASDAQ:GDRX
|
Accounts Receivables
$235.7m
|
CAGR 3-Years
26%
|
CAGR 5-Years
28%
|
CAGR 10-Years
N/A
|
|
|
Veeva Systems Inc
NYSE:VEEV
|
Accounts Receivables
$1.3B
|
CAGR 3-Years
19%
|
CAGR 5-Years
16%
|
CAGR 10-Years
25%
|
|
|
Inspire Medical Systems Inc
NYSE:INSP
|
Accounts Receivables
$119.7m
|
CAGR 3-Years
25%
|
CAGR 5-Years
37%
|
CAGR 10-Years
N/A
|
|
|
Doximity Inc
NYSE:DOCS
|
Accounts Receivables
$135.9m
|
CAGR 3-Years
19%
|
CAGR 5-Years
39%
|
CAGR 10-Years
N/A
|
|
|
Omnicell Inc
NASDAQ:OMCL
|
Accounts Receivables
$216.9m
|
CAGR 3-Years
-10%
|
CAGR 5-Years
3%
|
CAGR 10-Years
7%
|
|
|
W
|
Waystar Holding Corp
NASDAQ:WAY
|
Accounts Receivables
$177m
|
CAGR 3-Years
18%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Goodrx Holdings Inc
Glance View
GoodRx Holdings Inc., established at the intersection of healthcare and technology, has carved a niche in the American pharmaceutical industry by addressing one of its most notorious challenges: the high cost of prescription medications. Originally founded in 2011, GoodRx aims to ease the financial burden of medication costs for consumers by providing a platform that aggregates drug pricing information from pharmacies across the United States. By doing so, it empowers users to compare prices, identify potential savings, and subsequently make informed decisions about their medication purchases. At its core, GoodRx operates as a digital intermediary; its app and website seamlessly connect consumers with discounted prescription offers through partnerships with pharmacy benefit managers (PBMs) and retail pharmacies. The company's revenue model is primarily built on a commission and advertising framework. When users select a coupon from GoodRx and purchase at a pharmacy, the company receives a fee from its pharmacy partners or PBMs. Additionally, GoodRx leverages its vast user base, which is largely driven by organic traffic resulting from the essential nature of its service, to generate advertising revenues from pharmaceutical companies and other health-related entities eager to reach consumers actively seeking medication solutions. By continually expanding its services, such as telehealth offerings and a subscription model called GoodRx Gold, the company seeks to deepen its integration into the consumer healthcare experience while maintaining its core mission of providing accessible and affordable medication options.
See Also
What is Goodrx Holdings Inc's Accounts Receivables?
Accounts Receivables
235.7m
USD
Based on the financial report for Dec 31, 2025, Goodrx Holdings Inc's Accounts Receivables amounts to 235.7m USD.
What is Goodrx Holdings Inc's Accounts Receivables growth rate?
Accounts Receivables CAGR 5Y
28%
Over the last year, the Accounts Receivables growth was 62%. The average annual Accounts Receivables growth rates for Goodrx Holdings Inc have been 26% over the past three years , 28% over the past five years .